Gouw SC - Search Results

1

Patient-Centered Digital Health Records and Their Effects on Health Outcomes: Systematic Review.

Brands MR, Gouw SC, Beestrum M, Cronin RM, Fijnvandraat K, Badawy SM. Brands MR, et al. Among authors: gouw sc. J Med Internet Res. 2022 Dec 22;24(12):e43086. doi: 10.2196/43086. J Med Internet Res. 2022. PMID: 36548034 Free PMC article. Review.

2

Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A.

Gouw SC, van den Berg HM, le Cessie S, van der Bom JG. Gouw SC, et al. J Thromb Haemost. 2007 Jul;5(7):1383-90. doi: 10.1111/j.1538-7836.2007.02595.x. Epub 2007 Apr 20. J Thromb Haemost. 2007. PMID: 17456190 Free article.

3

Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.

Ter Avest PC, Fischer K, Gouw SC, Van Dijk K, Mauser-Bunschoten EP. Ter Avest PC, et al. Among authors: gouw sc. Haemophilia. 2010 May;16(102):71-9. doi: 10.1111/j.1365-2516.2010.02225.x. Haemophilia. 2010. PMID: 20536988

4

Mortality of patients with haemophilia in Brazil: First report.

Jardim LL, van der Bom JG, Caram-Deelder C, Gouw SC, Leal Cherchiglia M, Meireles Rezende S. Jardim LL, et al. Among authors: gouw sc. Haemophilia. 2019 May;25(3):e146-e152. doi: 10.1111/hae.13730. Epub 2019 Mar 15. Haemophilia. 2019. PMID: 30875453

5

The multifactorial etiology of inhibitor development in hemophilia: genetics and environment.

Gouw SC, van den Berg HM. Gouw SC, et al. Semin Thromb Hemost. 2009 Nov;35(8):723-34. doi: 10.1055/s-0029-1245105. Epub 2010 Feb 18. Semin Thromb Hemost. 2009. PMID: 20169509 Review.

6

Prenatal diagnosis for haemophilia: a nationwide survey among female carriers in the Netherlands.

Balak DM, Gouw SC, Plug I, Mauser-Bunschoten EP, Vriends AH, Van Diemen-Homan JE, Rosendaal FR, van der Bom JG. Balak DM, et al. Among authors: gouw sc. Haemophilia. 2012 Jul;18(4):584-92. doi: 10.1111/j.1365-2516.2011.02742.x. Epub 2012 Jan 18. Haemophilia. 2012. PMID: 22250892 Free article.

7

Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice.

ter Avest PC, Fischer K, Mancuso ME, Santagostino E, Yuste VJ, van den Berg HM, van der Bom JG; CANAL Study Group. ter Avest PC, et al. J Thromb Haemost. 2008 Dec;6(12):2048-54. doi: 10.1111/j.1538-7836.2008.03187.x. Epub 2008 Oct 7. J Thromb Haemost. 2008. PMID: 18983511 Free article.

8

Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study.

Gouw SC, van der Bom JG, Auerswald G, Ettinghausen CE, Tedgård U, van den Berg HM. Gouw SC, et al. Blood. 2007 Jun 1;109(11):4693-7. doi: 10.1182/blood-2006-11-056317. Epub 2007 Jan 11. Blood. 2007. PMID: 17218379 Free article.

9

Vaccinations are not associated with inhibitor development in boys with severe haemophilia A.

Platokouki H, Fischer K, Gouw SC, Rafowicz A, Carcao M, Kenet G, Liesner R, Kurnik K, Rivard GE, van den Berg HM. Platokouki H, et al. Among authors: gouw sc. Haemophilia. 2018 Mar;24(2):283-290. doi: 10.1111/hae.13387. Epub 2017 Dec 15. Haemophilia. 2018. PMID: 29243367

10

Gouw SC, van der Bom JG, Marijke van den Berg H. Gouw SC, et al. Blood. 2007 Jun 1;109(11):4648-54. doi: 10.1182/blood-2006-11-056291. Epub 2007 Feb 8. Blood. 2007. PMID: 17289808 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page